Literature DB >> 29735237

Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study.

Joseph D Perazzo, Allison R Webel, S M Khurshid Alam, Abdus Sattar, Grace A McComsey.   

Abstract

We conducted a cross-sectional secondary analysis of baseline data from the SATURN-HIV study (N = 147; 78% male, 68% Black, median body mass index [BMI] 26.72 kg/m2, 13% with osteopenia, HIV-1 RNA < 1,000 copies/mL, stable antiretroviral therapy [ART]) to explore the relationship between physical activity (PA) and bone mineral density (BMD). We measured self-reported minutes of PA and BMD in the overall sample and subgroups based on national recommendations (≥150 minutes/week). Forty-one (28%) participants met recommended PA levels. Higher intensity PA was associated with higher BMD at the total hip (r = 0.27, p = .09; n = 41; 28%) and lumbar spine (r = 0.32, p < .05), and predicted higher BMD at the hip (p < .01; controlling for age, BMI, ART). Lumbar spine BMD did not retain significance in the regression model. Moderate-to-high intensity PA could prevent or mitigate excessive bone loss in people living with HIV.
Copyright © 2018 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; bone; exercise; osteoporosis; physical activity

Mesh:

Substances:

Year:  2018        PMID: 29735237      PMCID: PMC5999576          DOI: 10.1016/j.jana.2018.03.004

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  42 in total

Review 1.  Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.

Authors:  Yamnia I Cortés; Michael T Yin; Nancy K Reame
Journal:  J Assoc Nurses AIDS Care       Date:  2015-04-03       Impact factor: 1.354

2.  Impact of Strength Training on Bone Mineral Density in Patients Infected With HIV Exhibiting Lipodystrophy.

Authors:  Wlaldemir R Santos; Walmir R Santos; Pedro P Paes; Isac A Ferreira-Silva; André P Santos; Natan Vercese; Dalmo R L Machado; Francisco José A de Paula; Eduardo A Donadi; Anderson M Navarro; Ana Paula M Fernandes
Journal:  J Strength Cond Res       Date:  2015-12       Impact factor: 3.775

3.  Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.

Authors:  Todd T Brown; Carlee Moser; Judith S Currier; Heather J Ribaudo; Jennifer Rothenberg; Theodoros Kelesidis; Otto Yang; Michael P Dubé; Robert L Murphy; James H Stein; Grace A McComsey
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

4.  Therapeutic options for low bone mineral density in HIV-infected subjects.

Authors:  Aoife G Cotter; Patrick W G Mallon
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

5.  Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Authors:  Todd T Brown; Allison C Ross; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  Antivir Ther       Date:  2011

6.  Continuous antiretroviral therapy decreases bone mineral density.

Authors:  Birgit Grund; Grace Peng; Cynthia L Gibert; Jennifer F Hoy; Rachel L Isaksson; Judith C Shlay; Esteban Martinez; Peter Reiss; Fehmida Visnegarwala; Andrew D Carr
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

Review 7.  Bone loss in HIV: a contemporary review.

Authors:  Corrilynn O Hileman; Allison Ross Eckard; Grace A McComsey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

8.  Long-Term Exercise and Bone Mineral Density Changes in Postmenopausal Women--Are There Periods of Reduced Effectiveness?

Authors:  Wolfgang Kemmler; Klaus Engelke; Simon von Stengel
Journal:  J Bone Miner Res       Date:  2015-09-03       Impact factor: 6.741

9.  The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation.

Authors:  Carine Beaupere; Marie Garcia; Jerome Larghero; Bruno Fève; Jacqueline Capeau; Claire Lagathu
Journal:  Aging Cell       Date:  2015-04-07       Impact factor: 9.304

10.  Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Authors:  Todd T Brown; Grace A McComsey; Martin S King; Roula B Qaqish; Barry M Bernstein; Barbara A da Silva
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.771

View more
  7 in total

1.  The effect of increased physical activity on symptom burden in older persons living with HIV.

Authors:  Patricia A Cioe; Rebecca E F Gordon; David M Williams; Christopher W Kahler
Journal:  AIDS Care       Date:  2019-04-08

2.  Short Communication: Low Muscle Mass Is Associated with Osteoporosis in Older Adults Living with HIV.

Authors:  Krisann K Oursler; Ali Iranmanesh; Chani Jain; Kim L Birkett; Brandon C Briggs; Dorothy C Garner; John D Sorkin; Alice S Ryan
Journal:  AIDS Res Hum Retroviruses       Date:  2019-12-23       Impact factor: 2.205

3.  Evidence-informed practical recommendations for increasing physical activity among persons living with HIV.

Authors:  Jessica L Montoya; Catherine M Jankowski; Kelly K O'Brien; Allison R Webel; Krisann K Oursler; Brook L Henry; David J Moore; Kristine M Erlandson
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.177

4.  Fractures in children and adolescents living with perinatally acquired HIV.

Authors:  Denise L Jacobson; Wendy Yu; Rohan Hazra; Sean Brummel; Mitchell E Geffner; Kunjal Patel; William Borkowsky; Jiajia Wang; Janet S Chen; Ayesha Mirza; Linda A DiMeglio
Journal:  Bone       Date:  2020-06-30       Impact factor: 4.398

5.  Effects of maximal strength training on bone mineral density in people living with HIV and receiving anti-retroviral therapy: a pilot study.

Authors:  Enock M Chisati; Demitri Constantinou; Fanuel Lampiao
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-10-23

6.  Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.

Authors:  Enock M Chisati; Demitri Constantinou; Fanuel Lampiao
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

7.  Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study.

Authors:  Christa Ellis; Herculina S Kruger; Michelle Viljoen; Joel A Dave; Marlena C Kruger
Journal:  Nutrients       Date:  2021-06-18       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.